The University of Hong Kong
Hong Kong, 0000
NCT Number: NCT06579833
Histotripsy is a promising non-invasive technique that uses high-intensity ultrasound waves to disrupt tissue without damaging surrounding structures. It works by using high-intensity ultrasound waves to create microscopic bubbles within the tumour tissue. These bubbles rapidly expand and collapse, generating shock waves that disrupt the tissue. The technique is highly precise and can be targeted to specific areas of the liver, allowing for selective destruction of tumour cells while minimizing damage to healthy tissue. This study will enrol 20 patients with liver tumours (be it primary or secondary liver tumours), monitor their post-operative adverse events, and study the changes in tumour size and volume after treatment. Histotripsy will be performed under general anaesthesia, with real-time monitoring by ultrasound, and deliver high-intensity ultrasound waves in single session or multiple sessions. Similar to other minimal invasive treatments, patients will be admitted 1 day prior, then receive Histotripsy on the next day and stay overnight for observation. Patients will be discharged on the 3rd day if unremarkable. During the hospital stay, blood samplings will be taken for evaluation around 2-4 times in total depending on the length of hospital stay.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Hong Kong, 0000
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Histotripsy is a promising non-invasive technique that uses high-intensity ultrasound waves to disrupt tissue without damaging surrounding structures. It works by using high-intensity ultrasound waves to create microscopic bubbles within the tumour tissue. These bubbles rapidly expand and collapse, generating shock waves that disrupt the tissue. The technique is highly precise and can be targeted to specific areas of the liver, allowing for selective destruction of tumour cells while minimizing damage to healthy tissue.
Other names: HistoSonics
Time frame: up to 36 months
Changes in tumour size and volume before and after intervention
Time frame: The whole duration of hospital stay, normally 3 days on average
Post procedure adverse events and complication
The University of Hong Kong
Other
Histotripsy (HistoSonics®) for Liver Tumours: a Phase II Safety and Efficacy Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01082419
Adenocarcinoma, Biliary Cholestasis
Bordeaux, France
View Trial DetailsNCT02181075
Adenocarcinoma, Carcinoma
Oxford, United Kingdom
View Trial DetailsNCT02041065
Adenocarcinoma, Carcinoma
Stockholm, Sweden
View Trial DetailsNCT04194775
Adenocarcinoma, Carcinoma
Coronado, California, United States
View Trial Details